Biogroup CFO Sees Huge Demand in Covid-19 Testing

Sep.09 -- Severine Bersauter, chief financial officer at Biogroup-LCD, discusses the possibility of a covid-19 vaccine, how the virus has impacted lab testing and consolidation in the industry. She speaks on “Bloomberg Daybreak: Europe.”
View on YouTube